Study of the Benefits of Virtual Reality Headsets for Reducing Anxiety in Patients Treated for Pleural Effusion or Pneumothorax Using Small-bore Chest Drainage Tubes
NCT ID: NCT07206940
Last Updated: 2025-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
38 participants
INTERVENTIONAL
2025-11-27
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reality virtual
Standard support with reality virtual headset
Drainage with Headset Hypno VR
Pleural effusion and pneumothorax will be drained with the patient wearing the virtual reality headset.
Standard of care
Standard support without reality virtual headset
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Drainage with Headset Hypno VR
Pleural effusion and pneumothorax will be drained with the patient wearing the virtual reality headset.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient requiring Sledinger thoracic drainage for pneumothorax or pleural effusion in the pulmonology department of Nice University Hospital;
* Patient affiliated with social security;
* Signature of informed consent.
Exclusion Criteria
* Anxiolytic, antidepressant, or psychotropic treatment already in place;
* Cognitive, behavioral, or psychiatric disorders;
* Language barrier;
* History of chest drainage or chest surgery;
* Hearing disorders without hearing aids;
* Vision disorders without corrective lenses (lack of binocular vision, blindness);
* Psychotic patients or patients diagnosed with psychiatric disorders;
* History of epilepsy;
* Current migraine;
* Patients for whom three-dimensional films are contraindicated (pacemaker or defibrillator);
* No social security coverage;
* Patients under guardianship/curatorship.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nelly BANSE
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Nice - Hôpital Pasteur 2
Nice, Alpes-Maritimes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-AOI-01
Identifier Type: -
Identifier Source: org_study_id